TGF-beta signal transduction inhibitors (Kyoto University)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameTGF-beta signal transduction inhibitors (Kyoto University)
Drug Alias NameEMT inhibitors (Kyoto University)epithelial-mesenchymal transition inhibitors (Kyoto University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 modulators
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsFibrosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyoto University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKansai Technology Licensing Organization Co LtdKyoto University
Active IndicationsN/A
Inactive IndicationsFibrosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A